Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 5/20 | 1.00 |
| ▸ | FUCA2 | Q9BTY2 | 1/20 | 1.00 |
| ▸ | GLB1 | P16278 | 1/20 | 0.58 |
| ▸ | GBA1 | P04062 | 5/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | GANAB | Q14697 | 1/20 | 0.46 |
| ▸ | MAN2B1 | O00754 | 1/20 | 0.46 |
| ▸ | MAN2B2 | Q9Y2E5 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deoxyfuconojirimycin SCHEMBL15686574 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL13876082 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL4378188 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL12581516 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL9999893 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL13328524 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL2436650 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL15691930 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL13876087 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA | |
| Deoxyfuconojirimycin SCHEMBL2435560 | 1.00 | FUCA1 (1.00) | FUCA1FUCA2GLB1GBA1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114174263-B | Non-lysosomal glucosylceramidase inhibitors and uses thereof | 阿勒克图治疗公司 | 2025-01-10 | — | — | CN | claimed |
| CN-114174263-A | Non-lysosomal glucosylceramidase inhibitors and uses thereof | 阿勒克图治疗公司 | 2022-03-11 | — | — | CN | claimed |
| US-20030204091-A1 | Process for the preparation of 1, 5-dideoxy-1,5-imino hexitols from oximes or imines | MICHIGAN STATE UNIVERSITY | 2003-10-30 | — | — | US | claimed |
| US-20030109710-A1 | PROCESS FOR THE PREPARATION OF 1,5-DIDEOXY-1,5-IMINO HEXITOLS FROM OXIMES OR IMINES | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2003-06-12 | — | — | US | claimed |
| US-6462197-B2 | REACTING A KETOALDONIC ACID METHYL ESTER OF THE SUGAR WITH THE PROTECTED HYDROXYL GROUPS WITH AN ALKYLAMINE OR HYDROXYAMINE ACID SALT WITH A TERTIARY AMINE TO REACT WITH AN ACID GENERATED IN THE REACTION TO PRODUCE OXIME METHYL ESTER | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2002-10-08 | — | — | US | claimed |
| US-20020068819-A1 | Process for the preparation of 1,5-dideoxy-1, 5-imino hexitols from oximes or imines | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2002-06-06 | — | — | US | claimed |
| US-20020052506-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2002-05-02 | — | — | US | claimed |
| US-20020052505-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2002-05-02 | — | — | US | claimed |
| US-20020016447-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2002-02-07 | — | — | US | claimed |
| US-20020016448-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2002-02-07 | — | — | US | claimed |
| US-20010049443-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2001-12-06 | — | — | US | claimed |
| US-12612380-B2 | Non-lysosomal glucosylceramidase inhibitors and uses thereof | ALECTOS THERAPEUTICS 1NC (CA) | 2026-04-28 | — | — | US | disclosed |
| CN-114174263-B | Non-lysosomal glucosylceramidase inhibitors and uses thereof | 阿勒克图治疗公司 | 2025-01-10 | — | — | CN | disclosed |
| US-20220213058-A1 | NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC. (CA) | 2022-07-07 | — | — | US | disclosed |
| CN-114174263-A | Non-lysosomal glucosylceramidase inhibitors and uses thereof | 阿勒克图治疗公司 | 2022-03-11 | — | — | CN | disclosed |
| EP-0884050-A1 | Use of 3,4-dihydroxy-2-hydroxymethylpyrrolidine for the treatment of diabetes | NOVO NORDISK A/S (DK) | 1998-12-16 | — | — | EP | disclosed |
| EP-0858335-A1 | 2-ALKYLPYRROLIDINES | NOVO NORDISK A/S (DK) | 1998-08-19 | — | — | EP | disclosed |
| WO-1997009040-A1 | 2-ALKYLPYRROLIDINES | NOVO NORDISK A/S (DK) | 1997-03-13 | — | — | WO | disclosed |
| EP-0749423-A1 | PIPERIDINES AND PYRROLIDINES | NOVO NORDISK A/S (DK) | 1996-12-27 | — | — | EP | disclosed |
| WO-1995024391-A1 | PIPERIDINES AND PYRROLIDINES | NOVO NORDISK A/S (DK) | 1995-09-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016448-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | GALE, HK1, G6PD | FUCA1 1170/4885FUCA2 870/4885GLB1 380/4885 |
| US-20010049443-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | GALE, HK1, G6PD | FUCA1 1053/4885FUCA2 756/4885GLB1 354/4885 |
| US-20030109710-A1 | PROCESS FOR THE PREPARATION OF 1,5-DIDEOXY-1,5-IMINO HEXITOLS FROM OXIMES OR IMINES | GALE, HK1, G6PD | FUCA1 1170/4885FUCA2 870/4885GLB1 380/4885 |
| US-20020052506-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | GALE, HK1, G6PD | FUCA1 1170/4885FUCA2 870/4885GLB1 380/4885 |
| US-20220213058-A1 | NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF | GBA1, GBA2, GAA | FUCA1 66/4885FUCA2 61/4885GLB1 78/4885 |
| US-20020068819-A1 | Process for the preparation of 1,5-dideoxy-1, 5-imino hexitols from oximes or imines | GALE, HK1, G6PD | FUCA1 1170/4885FUCA2 870/4885GLB1 380/4885 |
| US-12612380-B2 | Non-lysosomal glucosylceramidase inhibitors and uses thereof | GBA1, GBA2, MAN2B1 | FUCA1 22/4885FUCA2 23/4885GLB1 48/4885 |
| US-20020016447-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | GALE, HK1, G6PD | FUCA1 1170/4885FUCA2 870/4885GLB1 380/4885 |
| US-20030204091-A1 | Process for the preparation of 1, 5-dideoxy-1,5-imino hexitols from oximes or imines | GALE, HK1, G6PD | FUCA1 1170/4885FUCA2 870/4885GLB1 380/4885 |
| US-20020052505-A1 | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | GALE, HK1, G6PD | FUCA1 1170/4885FUCA2 870/4885GLB1 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.